AI assistant
RSA INSURANCE GROUP LIMITED Director's Dealing 2021
4719_dirs_2021-03-10_0b94c432-8a1e-4ed0-a7a0-dd7831866666.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 8481R
RSA Insurance Group PLC
10 March 2021
RSA Insurance Group plc
("the Company")
Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")
Ordinary Shares of £1.00 each
10 March 2021
The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Ordinary Shares").
On 8 March 2021 the Company granted the following Conditional Awards over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) to the following PDMRs at nil cost:
| Name | No. of Bonus Deferral Shares Awarded |
| Stephen Hester | 124,441 |
| Charlotte Jones | 60,212 |
| Scott Egan | 47,195 |
| Martin Thompson | 50,478 |
| Nathan Williams | 31,295 |
| Karen Caddick | 27,361 |
| Ralph Daals | 15,389 |
| Charlotte Heiss | 15,691 |
| William McDonnell | 21,099 |
| Ken Norgrove | 9,538 - vesting date 10 March 2021 23,846 - vesting date 8 March 2025 |
Bonus Deferral Shares:
Awards of Bonus Deferral Shares are granted as part of the Annual Bonus award. In line with regulatory requirements in Scandinavia, 9,538 of the shares subject to the award granted to Ken Norgrove vested immediately on 10 March 2021. Under normal circumstances and in line with regulatory requirements in Scandinavia, the balance of 23,846 shares will vest on 8 March 2025. A six-month holding period is applicable to these share awards, from the relevant vesting date.
Under normal circumstances, Awards of Bonus Deferral Shares will vest on 8 March 2024 (except for Ken Norgrove), subject to the rules of the PSP and the provisions of the Company's approved Remuneration Policy.
On 10 March 2021 the nil cost Conditional Awards over Shares granted on 8 March 2021 under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMR vested as shown in the table below
| Name | No. of Bonus Deferral Shares Vested | No. of Shares sold to cover statutory deductions |
| Ken Norgrove | 9,538 | 4,975 |
The forms required under the EU Market Abuse Regulation follow.
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Stephen Hester
b)
Position / status
Group Chief Executive
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 124,441 |
d)
Aggregated information
- Aggregated volume
- Price
124,441
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Charlotte Jones
b)
Position / status
Group Chief Financial Officer
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 60,212 |
d)
Aggregated information
- Aggregated volume
- Price
60,212
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Scott Egan
b)
Position / status
CEO, UK and International
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 47,195 |
d)
Aggregated information
- Aggregated volume
- Price
47,195
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Martin Thompson
b)
Position / status
CEO, Canada
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 50,478 |
d)
Aggregated information
- Aggregated volume
- Price
50,478
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Nathan Williams
b)
Position / status
Group Underwriting Director
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 31,295 |
d)
Aggregated information
- Aggregated volume
- Price
31,295
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Karen Caddick
b)
Position / status
Group and UK&I HR Director
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 27,361 |
d)
Aggregated information
- Aggregated volume
- Price
27,361
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Ralph Daals
b)
Position / status
Group Chief Auditor
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 15,389 |
d)
Aggregated information
- Aggregated volume
- Price
15,389
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Charlotte Heiss
b)
Position / status
Group General Counsel and Company Secretary
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 15,691 |
d)
Aggregated information
- Aggregated volume
- Price
15,691
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
William McDonnell
b)
Position / status
Group Chief Risk Officer
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 21,099 |
d)
Aggregated information
- Aggregated volume
- Price
21,099
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Persons Closely Associated ("PCA")
a)
Name
Ken Norgrove
b)
Position / status
CEO, RSA Scandinavia
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost with a vesting date of 8 March 2025.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 23,846 |
d)
Aggregated information
- Aggregated volume
- Price
23,846
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost with a vesting date of 10 March 2021.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 9,538 |
d)
Aggregated information
- Aggregated volume
- Price
9,538
NIL
e)
Date of the transaction
2021-03-08
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 10 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares (less any sold to cover statutory deductions) are subject to a six-month holding period which ends on 10 September 2021.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 9,538 |
d)
Aggregated information
- Aggregated volume
- Price
9,538
Nil
e)
Date of the transaction
2021-03-10
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 10 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| GBP 6.78 | 4,975 |
d)
Aggregated information
- Aggregated volume
- Price
4,975
GBP 6.78
e)
Date of the transaction
2021-03-10
f)
Place of the transaction
XLON London Stock Exchange
Enquiries to:
Christopher Smyth, Deputy Group Company Secretary
RSA Insurance Group plc
Tel: +44 (0) 20 7111 7000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGZGMFVGRGMZM